On Apr. 21, 2020, OpGen announced the start of an investigator initiated collaboration with Karolinska Institutet, Sweden, to…
On Apr. 21, 2020, LabCorpï¾® announced it has received an Emergency Use Authorization (EUA) from the FDA. The…
On Apr. 21, 2020, Quest Diagnostics announced that it has begun to perform antibody testing for coronavirus (COVID-19)…
On Apr. 21, 2020, Rutgers University announced it has launched the nation’s largest prospective study of health care…
On Apr. 21, 2020,the fight against the coronavirus is underway in a Rutgers Universityï¾–Camden research laboratory, where chemistry…
On Apr. 21, 2020, Todos Medical announced that Gnomegen has received Emergency Use Authorization from the FDA for…
On Apr. 21, 2020, Immunic reported that its lead asset, IMU-838, a selective oral DHODH inhibitor successfully demonstrated…
On Apr. 21, 2020, to fight the novel coronavirus pandemic, Cleveland Clinic and SAS announced they had created…
On Apr. 21, 2020, Pharnext and the University Hospital Institute Mediterranee Infection in France, announced a new joint…
On Apr. 20, 2020, Novartis has reached an agreement with the FDA to proceed with a Phase III…
On Apr. 20, 2020, RedHill Biopharma announced an agreement with the National Institute of Allergy and Infectious Diseases…
On Apr. 20, 2020, University of Southern California (USC) and the Los Angeles County Department of Public Health…
On Apr. 20, 2020, a multi-site project, called ‘What’s the STORY?’ received funding from UK Research and Innovation…
On Apr. 20, 2020, Anixa Biosciences announced it had entered into a strategic collaboration with OntoChem GmbH to…
On Apr. 20, 2020, Alexion announced plans to initiate a global Phase 3 study to investigate ULTOMIRISï¾® (ravulizumab-cwvz)…
On Apr. 20, 2020, Innovation Pharma reported that based on molecular screening of 11,552 compounds comprising already FDA-approved…
On Apr. 20, 2020, IDEXX Labs announced the availability of the IDEXX SARS-CoV-2 (COVID-19) RealPCR Test for pets….
On Apr. 20, 2020, VGX signed as the first occupant of Conroeï¾’s Deison Technology Park and will move…
On Apr. 20, 2020, the Rice University COVID-19 Research Fund Oversight and Review Committee announced it will support…
On Apr. 20, 2020, Atossa Therapeutics announced that it had applied to the FDA for approval to commence…
On Apr. 17, 2020, the NIH and the Foundation for the NIH are bringing together more than a…
On Apr. 17, 2020, the NIH announced that early treatment with the experimental antiviral drug remdesivir significantly reduced…
On Apr. 17, 2020, as part of Project Orbis, the U.S. Food and Drug Administration (FDA) approved Seagen’s…
On Apr. 17, 2020, five projects from across Oxford University’s Medical Sciences Division were among twenty-one new studies…
On Apr. 17, 2020, Roche announced the development and upcoming launch of its Elecsys Anti-SARS-CoV-2 serology test to…
On Apr. 17, 2020, Kaiser Permanente Washington Health Research Institute (KPWHRI) announced that older adults were being enrolled…
On Apr. 17, 2020, Sinovac Biotech announced that the Company had commenced Phase I clinical trial, a randomized,…
On Apr. 17, 2020, after promising COVID-19 treatments in Germany, France, Italy, Spain and the U.S,, ExThera Medical’s…
On Apr. 17, 2020, Incyte announced the initiation of RUXCOVID, a global, randomized, double-blind, placebo-controlled phase 3 clinical…
On Apr. 17, 2020, Emory University announced it had begun enrolling adults over age 55 in the clinical…